About: Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $10.72 (+8.28%)
KURA NASDAQ Kura Oncology Inc
Kura Oncology Inc share price
Atividade de preço de KURA
Último preço
$ 10,720
Variação (24h)
0,82 USD (8,28%)
Volume
2.28M
Volume (média 4 sem.)
-
Abertura
$ 9,74
Variação do dia
$ 9,67 - $ 10,72
Fechamento anterior
$ 9,90
Último negócio
28 Oct, 8:13 pm GMT+0
Atrasado
28 Oct, 8:13 pm GMT+0
KURA price performance
Atrasado
28 Oct, 8:13 pm GMT+0
quote.marketSignals